In the August 29, 2012 edition of the MicroCap Investor, analyst Josh Levine featured Neuralstem (CUR) as a strong buy at 50 cents. Josh told his subscribers "Neuralstem (CUR) is on a mission to develop unique therapies for some of the most challenging medical maladies faced by healthcare practitioners today. But its shares are valued extremely modestly by the market, suggesting one of two things - either CUR is falling short in its mission; or it has yet to gain sufficient recognition and credibility on the Street and among a wide investor audience. As you might guess, I definitely think it's the latter."
Neuralstem's patented technology enables the ability to produce
neural stem cells of the human brain and spinal cord in commercial
quantities, and the ability to control the differentiation of these
cells constitutively into mature, physiologically relevant human neurons
and glia. Neuralstem is in an FDA-approved Phase I safety clinical
trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou
Gehrig's disease, and has been awarded orphan status designation by the
FDA.About Josh Levine's MicroCap Investor: http://www.levinesmicrocapinvestor.com
MicroCap Disclaimer/disclosure - http://www.levinesmicrocapinvestor.com/disclosure/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and access our 13 online stock directories 24/7 - water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
No comments:
Post a Comment